Last reviewed · How we verify
HY01
At a glance
| Generic name | HY01 |
|---|---|
| Sponsor | Heyu (Suzhou) Pharmaceutical Technology Co., Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Phase I Clinical Study of HY01 in Patients (PHASE1)
- Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- HY01 CI brief — competitive landscape report
- HY01 updates RSS · CI watch RSS
- Heyu (Suzhou) Pharmaceutical Technology Co., Ltd portfolio CI